Update on Portfolio . Sold off Paushak, Optemius Infracom, QGO finance and Shaily. Added Techno electric , Basilic Fly (New entrants) and bought additional Shivalik and HBL.
Updated portfolio with Q2 update on the stocks in portfolio below
| Stock Name | Avg Purchase Price | Current Price | % weightage | Investment Rationale |
|---|---|---|---|---|
| Navin Flourine | 680 | 3606 | 7.66 | Value Migration from Old generation flourine application to CDMO/Pharma/Battery chem. Q2 was poor. Still banking on the capex undertaken . FY 25 should be much better. |
| Arrow Green | 368 | 466 | 2.44 | Chequered Past. Low disclosures, but seems to be doing cutting edge research in Bio-Soluble space, Security products, Graphene, Specialty inks etc. Better Q2 on YOY basis . Will evaluate post Q3 results. |
| Guj Themis | 124 | 182 | 3.58 | Fermentation and API play. Dr.Sachin Patel is knowledgeable . Change of model helped. New capex . Moving up the vlaue chain with Rifapentin |
| HBL Power | 300 | 342 | 4.07 | Huge Tail winds of KAVACH (TCAS), Battery segment for 5G adoption & Defence |
| KPIT Tech | 40 | 1624 | 12.53 | Pure play on automotive Software and CASE. Prudent management. Long run way ahead. Excellent quarter . Has tailwinds behind them . ER&D space red hot. |
| Laurus Labs | 590 | 368 | 5.95 | Dr.Chavas brilliance. Successful migration from ARV player to CDMO , Formulation,API. Optionalities like Bio, Gene Therapy etc. (Q2 was poor , still optimistic on the optionalities) |
| Natural Capsule | 410 | 350 | 2.23 | Venturing into HPMC capsules, new capacity is coming online. API manufacturing . PLI play. (Will have to wait till FY26 for substatial growth to kick in from API) |
| Neuland Labs | 2000 | 5396 | 23.06 | From generic APIs to specialty APIs . Biotech customers and Innovator big pharma clients can take to nxt league. Excellent Q2 . Rerating happened. 12k Cr market cap possible. |
| Rategain Travel | 550 | 716 | 4.52 | Travel domain focussed SAAS company. Acts as a bridge between OTAs and Hotels, Airlines etc. AI powered. Excellent results . (What is the risk of AI ?) |
| Ugro Capital | 210 | 268 | 10.18 | Digital focussed NBFC in MSME space. Dr. Nath .10x AUM in 3 yr plan. (Huge expectations, ticks every column . Is it too good for the liking ? ) |
| Gufic Bio | 230 | 298 | 7.33 | Domestic pharma , Liophylisation, API, Botolinum Toxin. New Indore plant with CGMP coming up.Pranav Choksi is knowledgable. (Good come back in Q2 . Waiting for market to rerate) |
| IRIS Business | 126 | 135 | 3.36 | Excellent management pedigree, in the RegTech SAAS space, No competitors in the niche space. Transitioning from services to prodcuts. Micro Cap . Will add after Q3 , CEO looks to be a loud mouth |
| Bajaj Finance | 2338 | 7068 | 2.59 | Got the price right during covid. Not added since. |
| Shivalik Bimetal | 520 | 533 | 3.82 | Bimetal , Shunt Resistor opportunity for EV and Smart Meters. Huge Tail winds ahead. FY 24 might be slow, but huge runway ahead. Looking to add in dips . |
| Basilic Fly | 280 | 279 | 2.93 | Play on the vfx business outsourcing opportunity. SME stock growing at scorching pace with 0 debt and excellent ROCE. Want to play a basket approach after adding Phantom digital too. |
| Techno Electric | 655 | 726 | 3.74 | EPC business in Power Space. Has operations in entire valuchain from generation, distribution along with newly venturing into Data centre business. Stock on fire after exceptional Q2 results. |
| 100.00 |
| Subscribe To Our Free Newsletter |
